fbpx

Ramsay Healthcare

Spire shareholders reject acquisition by Ramsay, with 69.9% of votes in favour, thus falling short of the minimum 75% threshold required for the transaction to complete.

Ramsay FY22 revenue is forecast to be $14bn, EBITDA up 8% to $2.3bn, supporting a forward yield of 2.4%.

You're not a member!  Trial today

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2024 Investor Signals

Send our ASX Research to your Inbox

Or start a free thirty day trial for our full service, which includes our ASX Research.